Page 117 - AN-3-4

Advanced Neurology Stress accelerates parkinsonism in rats

doi: 10.1080/10253890.2018.1456525 2010;213(1):94-102.
40. Belda X, Fuentes S, Daviu N, Nadal R, Armario A. Stress- doi: 10.1016/j.bbr.2010.04.041
induced sensitization: The hypothalamic-pituitary-adrenal 48. Rudyk C, Dwyer Z, McNeill J, et al. Chronic unpredictable
axis and beyond. Stress. 2015;18(3):269-279.
stress influenced the behavioral but not the neurodegenerative
doi: 10.3109/10253890.2015.1067678 impact of paraquat. Neurobiol Stress. 2019;11:100179.
41. Lima AC, Meurer YSR, Bioni VS, et al. Female rats are doi: 10.1016/j.ynstr.2019.100179
resistant to cognitive, motor and dopaminergic deficits in 49. Faria RR, Abilio VC, Grassl C, et al. Beneficial effects
the reserpine-induced progressive model of Parkinson’s of vitamin C and vitamin E on reserpine-induced oral
disease. Front Aging Neurosci. 2021;13:757714.
dyskinesia in rats: critical role of striatal catalase activity.
doi: 10.3389/fnagi.2021.757714 Neuropharmacology. 2005;48(7):993-1001.
42. Harris RB, Zhou J, Youngblood BD, Smagin GN, Ryan DH. doi: 10.1016/j.neuropharm.2005.01.014
Failure to change exploration or saccharin preference in rats 50. Teixeira AM, Reckziegel P, Muller L, et al. Intense exercise
exposed to chronic mild stress. Physiol Behav. 1997;63(1):91-100.
potentiates oxidative stress in striatum of reserpine-treated
doi: 10.1016/s0031-9384(97)00425-3 animals. Pharmacol Biochem Behav. 2009;92(2):231-235.
43. Hemmerle AM, Herman JP, Seroogy KB. Stress, depression doi: 10.1016/j.pbb.2008.11.015
and Parkinson’s disease. Exp Neurol. 2012;233(1):79-86.
51. Chen Q, Niu Y, Zhang R, et al. The toxic influence of
doi: 10.1016/j.expneurol.2011.09.035 paraquat on hippocampus of mice: Involvement of oxidative
stress. Neurotoxicology. 2010;31(3):310-316.
44. Howells FM, Russell VA, Mabandla MV, Kellaway LA. Stress
reduces the neuroprotective effect of exercise in a rat model doi: 10.1016/j.neuro.2010.02.006
for Parkinson’s disease. Behav Brain Res. 2005;165(2):210-220.
52. Sugama S, Sekiyama K, Kodama T, et al. Chronic
doi: 10.1016/j.bbr.2005.06.044 restraint stress triggers dopaminergic and noradrenergic
neurodegeneration: Possible role of chronic stress in the onset
45. Lauretti E, Di Meco A, Merali S, Pratico D. Chronic behavioral
stress exaggerates motor deficit and neuroinflammation of Parkinson’s disease. Brain Behav Immun. 2016;51:39-46.
in the MPTP mouse model of Parkinson’s disease. Transl doi: 10.1016/j.bbi.2015.08.015
Psychiatry. 2016;6(2):e733.
53. Kula J, Gugula A, Blasiak A, et al. Diverse action of repeated
doi: 10.1038/tp.2016.1 corticosterone treatment on synaptic transmission, neuronal
plasticity, and morphology in superficial and deep layers of
46. Smith LK, Jadavji NM, Colwell KL, Katrina Perehudoff S,
Metz GA. Stress accelerates neural degeneration and the rat motor cortex. Pflugers Arch. 2017;469(11):1519-1532.
exaggerates motor symptoms in a rat model of Parkinson’s doi: 10.1007/s00424-017-2036-5
disease. Eur J Neurosci. 2008;27(8):2133-2146.
54. Metz GA, Jadavji NM, Smith LK. Modulation of motor function
doi: 10.1111/j.1460-9568.2008.06177.x by stress: A novel concept of the effects of stress and corticosterone
on behavior. Eur J Neurosci. 2005;22(5):1190-1200.
47. Wu HH, Wang S. Strain differences in the chronic mild
stress animal model of depression. Behav Brain Res. doi: 10.1111/j.1460-9568.2005.04285.x

Volume 3 Issue 4 (2024) 11 doi: 10.36922/an.4037